Skip to content

Topical Ketamine Analgesia in Children Undergoing Tonsillectomy: a Clinical and Serum Level Assays Study.

Topical Ketamine by Neubulization Method in Tonsillectomy

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02720406
Enrollment
100
Registered
2016-03-25
Start date
2016-04-30
Completion date
2018-12-31
Last updated
2019-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

The aim of this study is to evaluate the analgesia efficacy of local ketamine given by two different doses in pediatric patients undergoing tonsillectomy operations

Detailed description

In this double-blinded, clinically-controlled trial, 100 child will be randomized into four groups of 25 patients each; control group, intravenous ketamine group received 0.5mg iv. ketamine, and two local ketamine groups receiving local ketamine by nebulization in two different doses; 1 and 2mg/kg. The verbal rating pain scale, time to first postoperative analgesic request, total analgesic consumption during 1st 24 h postoperative, serum ketamine levels, intra operative blood loss, postoperative bleeding, and adverse effects were evaluated.

Interventions

DRUGIntravenous ketamine0.5mg/kg

Intravenous ketamine 0.5mg/kg after anesthesia and before surgery.

DRUGNebulized Ketamine 1mg/kg

Nebulized Ketamine 1mg/kg given by nebulizer before anesthesia.

DRUGNebulized Ketamine 2mg/kg

Nebulized Ketamine 2mg/kg given by nebulizer before anesthesia.

DRUGsaline placebo

Saline 0.9% given by nebulizer before anesthesia and iv after anesthesia and before surgery.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
7 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* ASA physical status I-II patients aged 7-12 years and scheduled for elective tonsillectomy due to recurrent or chronic tonsillitis will be included in the study

Exclusion criteria

* patients with known hypersensitivity to medication drugs, coagulation disorders, thrombocytopenia, and significant cardiac, renal, pulmonary or hepatic disease.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative analgesic consumption24 hours postoperativeThe total amount of analgesics used in the first 24h postoperative in mg.

Secondary

MeasureTime frameDescription
Postoperative pain scores24 hours postoperativePain intensity will be assessed postoperatively by using the Verbal Rating scale (VRS) (0 =no pain, 1 =mild pain, 2 =moderate pain, 3 =severe pain, and lastly 4 =excruciating pain). VRS assessments were performed at rest in the following time points; at arrival to PACU, 30 min, 1, 2, 3, 4, 5, 6, 12, and 24 h postoperative. \- \- .
Ketamine serum levels to exclude systemic absorption of topical ketamine.120 min after receiving Ketaminethe level of ketamine in the serum.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026